Clinical Trial Update: A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating ASP5541 in participants with prostate cancer, including metastatic castration-resistant and metastatic hormone-sensitive dis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Hormone-sensitive Prostate Cancer
• Prostate Cancer

Drugs mentioned

• ASP5541

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer | Phase 2 | Status: RECRUITING